188 related articles for article (PubMed ID: 37514156)
1. Editorial on Special Issue "Lipid Nanosystems for Local Drug Delivery".
Catita J; Lopes CM
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514156
[TBL] [Abstract][Full Text] [Related]
2. Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems.
Peters MCC; Santos Neto ED; Monteiro LM; Yukuyama MN; Machado MGM; de Oliveira IF; Zanin MHA; Löbenberg R; Bou-Chacra N
J Drug Target; 2020 Mar; 28(3):259-270. PubMed ID: 31491352
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the biocompatibility and skin hydration potential of vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies.
Vaz S; Silva R; Amaral MH; Martins E; Sousa Lobo JM; Silva AC
Colloids Surf B Biointerfaces; 2019 Jul; 179():242-249. PubMed ID: 30974262
[TBL] [Abstract][Full Text] [Related]
4. Designing lipid nanoparticles for topical ocular drug delivery.
Alvarez-Trabado J; Diebold Y; Sanchez A
Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury.
Ferreira-Silva M; Faria-Silva C; Baptista PV; Fernandes E; Fernandes AR; Corvo ML
Drug Deliv Transl Res; 2021 Apr; 11(2):397-410. PubMed ID: 33660214
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability.
Sumaila M; Marimuthu T; Kumar P; Choonara YE
AAPS PharmSciTech; 2021 Sep; 22(7):242. PubMed ID: 34595578
[TBL] [Abstract][Full Text] [Related]
7. Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.
Akombaetwa N; Ilangala AB; Thom L; Memvanga PB; Witika BA; Buya AB
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839978
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents.
Kotla NG; Chandrasekar B; Rooney P; Sivaraman G; Larrañaga A; Krishna KV; Pandit A; Rochev Y
ACS Biomater Sci Eng; 2017 Jul; 3(7):1262-1272. PubMed ID: 33440514
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin nanosystems in oral drug delivery: A mini review.
Adeoye O; Cabral-Marques H
Int J Pharm; 2017 Oct; 531(2):521-531. PubMed ID: 28455134
[TBL] [Abstract][Full Text] [Related]
10. Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases.
Caldas AR; Catita J; Machado R; Ribeiro A; Cerqueira F; Horta B; Medeiros R; Lúcio M; Lopes CM
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452163
[TBL] [Abstract][Full Text] [Related]
11. Editorial of Special Issue "The Self-Assembly and Design of Polyfunctional Nanosystems 2.0".
Kashapov R; Zakharova L
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457255
[TBL] [Abstract][Full Text] [Related]
12. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
[TBL] [Abstract][Full Text] [Related]
13. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance.
Gong J; Shi T; Liu J; Pei Z; Liu J; Ren X; Li F; Qiu F
Biomed Pharmacother; 2023 May; 161():114505. PubMed ID: 36921532
[TBL] [Abstract][Full Text] [Related]
14. Nanosystems for Skin Delivery: From Drugs to Cosmetics.
Antunes AF; Pereira P; Reis C; Rijo P; Reis C
Curr Drug Metab; 2017; 18(5):412-425. PubMed ID: 28266273
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery.
Abeylath SC; Ganta S; Iyer AK; Amiji M
Acc Chem Res; 2011 Oct; 44(10):1009-17. PubMed ID: 21761902
[TBL] [Abstract][Full Text] [Related]
16. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.
Lin G; Zhou J; Cheng H; Liu G
Small; 2023 Jul; 19(28):e2207973. PubMed ID: 36971279
[TBL] [Abstract][Full Text] [Related]
17. Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art.
Di Filippo LD; Duarte JL; Luiz MT; de Araújo JTC; Chorilli M
Curr Neuropharmacol; 2021; 19(6):787-812. PubMed ID: 32867643
[TBL] [Abstract][Full Text] [Related]
18. Editorial-Current Insights on Lipid-Based Nanosystems.
Silva AC; Moreira JN; Lobo JMS
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297379
[TBL] [Abstract][Full Text] [Related]
19. Editorial for the Special Issue on Heat and Mass Transfer in Micro/Nanosystems.
Wang R; Zhang J
Micromachines (Basel); 2022 Jul; 13(7):. PubMed ID: 35888968
[TBL] [Abstract][Full Text] [Related]
20. The Potential of Drug Delivery Nanosystems for Sepsis Treatment.
Shi Y; Zhu ML; Wu Q; Huang Y; Xu XL; Chen W
J Inflamm Res; 2021; 14():7065-7077. PubMed ID: 34984019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
